Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis Article Swipe
Masahiro Ogasawara
,
Rintaro Nozu
,
Kosuke Miki
,
Shunnsuke Sugimura
,
Keisuke Kojima
,
Daisuke Hidaka
,
Reiki Ogasawara
,
Kohei Okada
,
Junichi Sugita
,
Naoki Kobayashi
,
Masahiro Imamura
,
Shuichi Ota
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.2169/internalmedicine.1714-23
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.2169/internalmedicine.1714-23
Objective The prognosis of the patients who relapsed after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is poor, and therapeutic options are limited. In the present study, we investigated the efficacy and factors associated with the survival in patients with acute leukemia or myelodysplastic syndrome (MDS) who relapsed following allo-HSCT and were treated with donor lymphocyte infusion (DLI) in real-world practice. Patients Twenty-nine patients with acute myeloid leukemia21, acute lymphoid leukemia4 or MDS4 were enrolled. Eleven patients were diagnosed with hematological relapse, and 18 were diagnosed with molecular or cytogenetic relapse. Results The median injection number and median total number of infused CD3+ T cells were 2 and 5.0×107/kg, respectively. The cumulative incidence of acute graft-versus-host disease (aGVHD) of grade ≥II at 4 months after the initiation of DLI was 31.0%. Extensive chronic graft-versus-host disease (cGVHD) occurred in 3 (10.3%) patients. The overall response rate was 51.7%, including 3 cases of hematological complete remission (CR) and 12 cases of molecular/cytogenetic CR. Cumulative relapse rates at 24 and 60 months following DLI in patients who achieved CR were 21.4% and 30.0%, respectively. The overall survival rates at 1, 2 and 3 years after DLI were 41.4%, 37.9% and 30.3%, respectively. Molecular/cytogenetic relapse, a longer interval from HSCT to relapse, and concomitant chemotherapy with 5-azacytidine (Aza) were significantly associated with a relatively long survival following DLI. Conclusion These results indicated that DLI was beneficial for patients with acute leukemia or MDS who relapsed after allo-HSCT and suggested that DLI in combination with Aza for molecular or cytogenetic relapse might result in favorable outcomes.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.2169/internalmedicine.1714-23
- https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1714-23/_pdf
- OA Status
- diamond
- Cited By
- 3
- References
- 33
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4377691556
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4377691556Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2169/internalmedicine.1714-23Digital Object Identifier
- Title
-
Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective AnalysisWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-05-23Full publication date if available
- Authors
-
Masahiro Ogasawara, Rintaro Nozu, Kosuke Miki, Shunnsuke Sugimura, Keisuke Kojima, Daisuke Hidaka, Reiki Ogasawara, Kohei Okada, Junichi Sugita, Naoki Kobayashi, Masahiro Imamura, Shuichi OtaList of authors in order
- Landing page
-
https://doi.org/10.2169/internalmedicine.1714-23Publisher landing page
- PDF URL
-
https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1714-23/_pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1714-23/_pdfDirect OA link when available
- Concepts
-
Medicine, Hematopoietic stem cell transplantation, Donor lymphocyte infusion, Transplantation, Stem cell, Myelodysplastic syndromes, Acute leukemia, Oncology, Leukemia, Internal medicine, Haematopoiesis, Lymphocyte, Immunology, Bone marrow, Genetics, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
33Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4377691556 |
|---|---|
| doi | https://doi.org/10.2169/internalmedicine.1714-23 |
| ids.doi | https://doi.org/10.2169/internalmedicine.1714-23 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37225485 |
| ids.openalex | https://openalex.org/W4377691556 |
| fwci | 1.17042636 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D012189 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Retrospective Studies |
| mesh[2].qualifier_ui | Q000628 |
| mesh[2].descriptor_ui | D015470 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | therapy |
| mesh[2].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[3].qualifier_ui | Q000150 |
| mesh[3].descriptor_ui | D015470 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | complications |
| mesh[3].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[4].qualifier_ui | Q000628 |
| mesh[4].descriptor_ui | D009190 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | therapy |
| mesh[4].descriptor_name | Myelodysplastic Syndromes |
| mesh[5].qualifier_ui | Q000150 |
| mesh[5].descriptor_ui | D009190 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | complications |
| mesh[5].descriptor_name | Myelodysplastic Syndromes |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D000208 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Acute Disease |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D002908 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Chronic Disease |
| mesh[8].qualifier_ui | Q000209 |
| mesh[8].descriptor_ui | D006086 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | etiology |
| mesh[8].descriptor_name | Graft vs Host Disease |
| mesh[9].qualifier_ui | Q000009 |
| mesh[9].descriptor_ui | D018380 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | adverse effects |
| mesh[9].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[10].qualifier_ui | Q000379 |
| mesh[10].descriptor_ui | D018380 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | methods |
| mesh[10].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D012008 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Recurrence |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000095384 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Pathologic Complete Response |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D008214 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Lymphocytes |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D006801 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Humans |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D012189 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Retrospective Studies |
| mesh[16].qualifier_ui | Q000628 |
| mesh[16].descriptor_ui | D015470 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | therapy |
| mesh[16].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[17].qualifier_ui | Q000150 |
| mesh[17].descriptor_ui | D015470 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | complications |
| mesh[17].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[18].qualifier_ui | Q000628 |
| mesh[18].descriptor_ui | D009190 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | therapy |
| mesh[18].descriptor_name | Myelodysplastic Syndromes |
| mesh[19].qualifier_ui | Q000150 |
| mesh[19].descriptor_ui | D009190 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | complications |
| mesh[19].descriptor_name | Myelodysplastic Syndromes |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D000208 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Acute Disease |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D002908 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Chronic Disease |
| mesh[22].qualifier_ui | Q000209 |
| mesh[22].descriptor_ui | D006086 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | etiology |
| mesh[22].descriptor_name | Graft vs Host Disease |
| mesh[23].qualifier_ui | Q000009 |
| mesh[23].descriptor_ui | D018380 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | adverse effects |
| mesh[23].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[24].qualifier_ui | Q000379 |
| mesh[24].descriptor_ui | D018380 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | methods |
| mesh[24].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D012008 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Recurrence |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D000095384 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Pathologic Complete Response |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008214 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Lymphocytes |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D006801 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Humans |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D012189 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Retrospective Studies |
| mesh[30].qualifier_ui | Q000628 |
| mesh[30].descriptor_ui | D015470 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | therapy |
| mesh[30].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[31].qualifier_ui | Q000150 |
| mesh[31].descriptor_ui | D015470 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | complications |
| mesh[31].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[32].qualifier_ui | Q000628 |
| mesh[32].descriptor_ui | D009190 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | therapy |
| mesh[32].descriptor_name | Myelodysplastic Syndromes |
| mesh[33].qualifier_ui | Q000150 |
| mesh[33].descriptor_ui | D009190 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | complications |
| mesh[33].descriptor_name | Myelodysplastic Syndromes |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D000208 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Acute Disease |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D002908 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Chronic Disease |
| mesh[36].qualifier_ui | Q000209 |
| mesh[36].descriptor_ui | D006086 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | etiology |
| mesh[36].descriptor_name | Graft vs Host Disease |
| mesh[37].qualifier_ui | Q000009 |
| mesh[37].descriptor_ui | D018380 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | adverse effects |
| mesh[37].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[38].qualifier_ui | Q000379 |
| mesh[38].descriptor_ui | D018380 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | methods |
| mesh[38].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D012008 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Recurrence |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D000095384 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Pathologic Complete Response |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D008214 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Lymphocytes |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D006801 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Humans |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D012189 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Retrospective Studies |
| mesh[44].qualifier_ui | Q000628 |
| mesh[44].descriptor_ui | D015470 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | therapy |
| mesh[44].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[45].qualifier_ui | Q000150 |
| mesh[45].descriptor_ui | D015470 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | complications |
| mesh[45].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[46].qualifier_ui | Q000628 |
| mesh[46].descriptor_ui | D009190 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | therapy |
| mesh[46].descriptor_name | Myelodysplastic Syndromes |
| mesh[47].qualifier_ui | Q000150 |
| mesh[47].descriptor_ui | D009190 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | complications |
| mesh[47].descriptor_name | Myelodysplastic Syndromes |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D000208 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Acute Disease |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D002908 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Chronic Disease |
| type | article |
| title | Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis |
| biblio.issue | 2 |
| biblio.volume | 63 |
| biblio.last_page | 205 |
| biblio.first_page | 197 |
| topics[0].id | https://openalex.org/T10309 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2720 |
| topics[0].subfield.display_name | Hematology |
| topics[0].display_name | Acute Myeloid Leukemia Research |
| topics[1].id | https://openalex.org/T10345 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9998999834060669 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2720 |
| topics[1].subfield.display_name | Hematology |
| topics[1].display_name | Hematopoietic Stem Cell Transplantation |
| topics[2].id | https://openalex.org/T10950 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9986000061035156 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2739 |
| topics[2].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[2].display_name | Acute Lymphoblastic Leukemia research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9300827383995056 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777408962 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7387627959251404 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1128050 |
| concepts[1].display_name | Hematopoietic stem cell transplantation |
| concepts[2].id | https://openalex.org/C2779695342 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6811288595199585 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q5296800 |
| concepts[2].display_name | Donor lymphocyte infusion |
| concepts[3].id | https://openalex.org/C2911091166 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6135427355766296 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q106419912 |
| concepts[3].display_name | Transplantation |
| concepts[4].id | https://openalex.org/C28328180 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6064310669898987 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q48196 |
| concepts[4].display_name | Stem cell |
| concepts[5].id | https://openalex.org/C2780817109 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5595946907997131 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q954625 |
| concepts[5].display_name | Myelodysplastic syndromes |
| concepts[6].id | https://openalex.org/C2776863199 |
| concepts[6].level | 3 |
| concepts[6].score | 0.533299446105957 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q976388 |
| concepts[6].display_name | Acute leukemia |
| concepts[7].id | https://openalex.org/C143998085 |
| concepts[7].level | 1 |
| concepts[7].score | 0.523953914642334 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[7].display_name | Oncology |
| concepts[8].id | https://openalex.org/C2778461978 |
| concepts[8].level | 2 |
| concepts[8].score | 0.5055553913116455 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q29496 |
| concepts[8].display_name | Leukemia |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.4831823408603668 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C109159458 |
| concepts[10].level | 3 |
| concepts[10].score | 0.47349271178245544 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q919283 |
| concepts[10].display_name | Haematopoiesis |
| concepts[11].id | https://openalex.org/C2777761686 |
| concepts[11].level | 2 |
| concepts[11].score | 0.46697449684143066 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q715347 |
| concepts[11].display_name | Lymphocyte |
| concepts[12].id | https://openalex.org/C203014093 |
| concepts[12].level | 1 |
| concepts[12].score | 0.3293009400367737 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[12].display_name | Immunology |
| concepts[13].id | https://openalex.org/C2780007613 |
| concepts[13].level | 2 |
| concepts[13].score | 0.13246193528175354 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q546523 |
| concepts[13].display_name | Bone marrow |
| concepts[14].id | https://openalex.org/C54355233 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[14].display_name | Genetics |
| concepts[15].id | https://openalex.org/C86803240 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[15].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9300827383995056 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/hematopoietic-stem-cell-transplantation |
| keywords[1].score | 0.7387627959251404 |
| keywords[1].display_name | Hematopoietic stem cell transplantation |
| keywords[2].id | https://openalex.org/keywords/donor-lymphocyte-infusion |
| keywords[2].score | 0.6811288595199585 |
| keywords[2].display_name | Donor lymphocyte infusion |
| keywords[3].id | https://openalex.org/keywords/transplantation |
| keywords[3].score | 0.6135427355766296 |
| keywords[3].display_name | Transplantation |
| keywords[4].id | https://openalex.org/keywords/stem-cell |
| keywords[4].score | 0.6064310669898987 |
| keywords[4].display_name | Stem cell |
| keywords[5].id | https://openalex.org/keywords/myelodysplastic-syndromes |
| keywords[5].score | 0.5595946907997131 |
| keywords[5].display_name | Myelodysplastic syndromes |
| keywords[6].id | https://openalex.org/keywords/acute-leukemia |
| keywords[6].score | 0.533299446105957 |
| keywords[6].display_name | Acute leukemia |
| keywords[7].id | https://openalex.org/keywords/oncology |
| keywords[7].score | 0.523953914642334 |
| keywords[7].display_name | Oncology |
| keywords[8].id | https://openalex.org/keywords/leukemia |
| keywords[8].score | 0.5055553913116455 |
| keywords[8].display_name | Leukemia |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.4831823408603668 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/haematopoiesis |
| keywords[10].score | 0.47349271178245544 |
| keywords[10].display_name | Haematopoiesis |
| keywords[11].id | https://openalex.org/keywords/lymphocyte |
| keywords[11].score | 0.46697449684143066 |
| keywords[11].display_name | Lymphocyte |
| keywords[12].id | https://openalex.org/keywords/immunology |
| keywords[12].score | 0.3293009400367737 |
| keywords[12].display_name | Immunology |
| keywords[13].id | https://openalex.org/keywords/bone-marrow |
| keywords[13].score | 0.13246193528175354 |
| keywords[13].display_name | Bone marrow |
| language | en |
| locations[0].id | doi:10.2169/internalmedicine.1714-23 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S154471048 |
| locations[0].source.issn | 0918-2918, 1349-7235 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0918-2918 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Internal Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310313351 |
| locations[0].source.host_organization_name | The Japanese Society of Internal Medicine |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310313351 |
| locations[0].license | other-oa |
| locations[0].pdf_url | https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1714-23/_pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/other-oa |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Internal Medicine |
| locations[0].landing_page_url | https://doi.org/10.2169/internalmedicine.1714-23 |
| locations[1].id | pmid:37225485 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Internal medicine (Tokyo, Japan) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37225485 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10864080 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by-nc-nd |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10864080/pdf/1349-7235-63-0197.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Intern Med |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10864080 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5004999383 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-7919-7146 |
| authorships[0].author.display_name | Masahiro Ogasawara |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[0].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Masahiro Ogasawara |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[1].author.id | https://openalex.org/A5081195441 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Rintaro Nozu |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[1].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Rintaro Nozu |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[2].author.id | https://openalex.org/A5112920835 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Kosuke Miki |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[2].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Kosuke Miki |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[3].author.id | https://openalex.org/A5110979256 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Shunnsuke Sugimura |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[3].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[3].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Shunnsuke Sugimura |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[4].author.id | https://openalex.org/A5040490999 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-8430-384X |
| authorships[4].author.display_name | Keisuke Kojima |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[4].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Keisuke Kojima |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[5].author.id | https://openalex.org/A5048942582 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-2570-9166 |
| authorships[5].author.display_name | Daisuke Hidaka |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[5].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[5].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Daisuke Hidaka |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[6].author.id | https://openalex.org/A5060043861 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1136-5035 |
| authorships[6].author.display_name | Reiki Ogasawara |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[6].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[6].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Reiki Ogasawara |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[7].author.id | https://openalex.org/A5066545223 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Kohei Okada |
| authorships[7].countries | JP |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[7].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[7].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[7].institutions[0].country_code | JP |
| authorships[7].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Kohei Okada |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[8].author.id | https://openalex.org/A5060880610 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3852-5075 |
| authorships[8].author.display_name | Junichi Sugita |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[8].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[8].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Junichi Sugita |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[9].author.id | https://openalex.org/A5054830507 |
| authorships[9].author.orcid | https://orcid.org/0009-0006-0866-8517 |
| authorships[9].author.display_name | Naoki Kobayashi |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[9].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[9].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Naoki Kobayashi |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[10].author.id | https://openalex.org/A5034892457 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-5287-2770 |
| authorships[10].author.display_name | Masahiro Imamura |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[10].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[10].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Masahiro Imamura |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[11].author.id | https://openalex.org/A5049803192 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-3631-244X |
| authorships[11].author.display_name | Shuichi Ota |
| authorships[11].countries | JP |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210113341 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| authorships[11].institutions[0].id | https://openalex.org/I4210113341 |
| authorships[11].institutions[0].ror | https://ror.org/024czvm93 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210113341 |
| authorships[11].institutions[0].country_code | JP |
| authorships[11].institutions[0].display_name | Sapporo Hokuyu Hospital |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Shuichi Ota |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Hematology, Sapporo Hokuyu Hospital, Japan |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1714-23/_pdf |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10309 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2720 |
| primary_topic.subfield.display_name | Hematology |
| primary_topic.display_name | Acute Myeloid Leukemia Research |
| related_works | https://openalex.org/W2901503434, https://openalex.org/W2101221673, https://openalex.org/W2108739937, https://openalex.org/W1575781057, https://openalex.org/W2092506110, https://openalex.org/W2049759526, https://openalex.org/W2521842405, https://openalex.org/W2071824263, https://openalex.org/W1974725389, https://openalex.org/W2065010853 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.2169/internalmedicine.1714-23 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S154471048 |
| best_oa_location.source.issn | 0918-2918, 1349-7235 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0918-2918 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Internal Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310313351 |
| best_oa_location.source.host_organization_name | The Japanese Society of Internal Medicine |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310313351 |
| best_oa_location.license | other-oa |
| best_oa_location.pdf_url | https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1714-23/_pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/other-oa |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Internal Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.2169/internalmedicine.1714-23 |
| primary_location.id | doi:10.2169/internalmedicine.1714-23 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S154471048 |
| primary_location.source.issn | 0918-2918, 1349-7235 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0918-2918 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Internal Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310313351 |
| primary_location.source.host_organization_name | The Japanese Society of Internal Medicine |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310313351 |
| primary_location.license | other-oa |
| primary_location.pdf_url | https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1714-23/_pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/other-oa |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Internal Medicine |
| primary_location.landing_page_url | https://doi.org/10.2169/internalmedicine.1714-23 |
| publication_date | 2023-05-23 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2296458069, https://openalex.org/W2031897049, https://openalex.org/W1668548441, https://openalex.org/W2009379600, https://openalex.org/W1491993932, https://openalex.org/W2036116596, https://openalex.org/W1978474777, https://openalex.org/W3119384466, https://openalex.org/W1965130623, https://openalex.org/W2109948637, https://openalex.org/W1999431876, https://openalex.org/W2587940974, https://openalex.org/W3003559344, https://openalex.org/W2567601891, https://openalex.org/W2592855281, https://openalex.org/W2886922441, https://openalex.org/W4292415342, https://openalex.org/W4295346418, https://openalex.org/W2029047332, https://openalex.org/W1263703055, https://openalex.org/W2046843493, https://openalex.org/W2766106189, https://openalex.org/W4205365283, https://openalex.org/W2559537906, https://openalex.org/W2121960517, https://openalex.org/W2040073738, https://openalex.org/W2126857774, https://openalex.org/W1996628620, https://openalex.org/W2765151185, https://openalex.org/W2059465100, https://openalex.org/W3082155123, https://openalex.org/W3175898740, https://openalex.org/W2591717879 |
| referenced_works_count | 33 |
| abstract_inverted_index.2 | 105, 186 |
| abstract_inverted_index.3 | 137, 147, 188 |
| abstract_inverted_index.4 | 121 |
| abstract_inverted_index.T | 102 |
| abstract_inverted_index.a | 200, 217 |
| abstract_inverted_index.1, | 185 |
| abstract_inverted_index.12 | 155 |
| abstract_inverted_index.18 | 82 |
| abstract_inverted_index.24 | 164 |
| abstract_inverted_index.60 | 166 |
| abstract_inverted_index.CR | 174 |
| abstract_inverted_index.In | 22 |
| abstract_inverted_index.at | 120, 163, 184 |
| abstract_inverted_index.in | 36, 57, 136, 170, 246, 257 |
| abstract_inverted_index.is | 15 |
| abstract_inverted_index.of | 3, 99, 112, 117, 126, 149, 157 |
| abstract_inverted_index.or | 41, 70, 87, 236, 252 |
| abstract_inverted_index.to | 205 |
| abstract_inverted_index.we | 26 |
| abstract_inverted_index.Aza | 249 |
| abstract_inverted_index.CR. | 159 |
| abstract_inverted_index.DLI | 127, 169, 191, 228, 245 |
| abstract_inverted_index.MDS | 237 |
| abstract_inverted_index.The | 1, 91, 109, 140, 180 |
| abstract_inverted_index.and | 17, 30, 49, 81, 95, 106, 154, 165, 177, 187, 195, 207, 242 |
| abstract_inverted_index.are | 20 |
| abstract_inverted_index.for | 231, 250 |
| abstract_inverted_index.the | 4, 23, 28, 34, 124 |
| abstract_inverted_index.was | 128, 144, 229 |
| abstract_inverted_index.who | 6, 45, 172, 238 |
| abstract_inverted_index.(CR) | 153 |
| abstract_inverted_index.DLI. | 222 |
| abstract_inverted_index.HSCT | 204 |
| abstract_inverted_index.cell | 12 |
| abstract_inverted_index.from | 203 |
| abstract_inverted_index.long | 219 |
| abstract_inverted_index.rate | 143 |
| abstract_inverted_index.stem | 11 |
| abstract_inverted_index.that | 227, 244 |
| abstract_inverted_index.were | 50, 72, 76, 83, 104, 175, 192, 213 |
| abstract_inverted_index.with | 33, 38, 52, 63, 78, 85, 210, 216, 233, 248 |
| abstract_inverted_index.(Aza) | 212 |
| abstract_inverted_index.(DLI) | 56 |
| abstract_inverted_index.(MDS) | 44 |
| abstract_inverted_index.21.4% | 176 |
| abstract_inverted_index.37.9% | 194 |
| abstract_inverted_index.These | 224 |
| abstract_inverted_index.acute | 39, 64, 67, 113, 234 |
| abstract_inverted_index.after | 8, 123, 190, 240 |
| abstract_inverted_index.cases | 148, 156 |
| abstract_inverted_index.cells | 103 |
| abstract_inverted_index.donor | 53 |
| abstract_inverted_index.grade | 118 |
| abstract_inverted_index.might | 255 |
| abstract_inverted_index.poor, | 16 |
| abstract_inverted_index.rates | 162, 183 |
| abstract_inverted_index.total | 97 |
| abstract_inverted_index.years | 189 |
| abstract_inverted_index.≥II | 119 |
| abstract_inverted_index.30.0%, | 178 |
| abstract_inverted_index.30.3%, | 196 |
| abstract_inverted_index.31.0%. | 129 |
| abstract_inverted_index.41.4%, | 193 |
| abstract_inverted_index.51.7%, | 145 |
| abstract_inverted_index.Eleven | 74 |
| abstract_inverted_index.longer | 201 |
| abstract_inverted_index.median | 92, 96 |
| abstract_inverted_index.months | 122, 167 |
| abstract_inverted_index.number | 94, 98 |
| abstract_inverted_index.result | 256 |
| abstract_inverted_index.study, | 25 |
| abstract_inverted_index.(10.3%) | 138 |
| abstract_inverted_index.(aGVHD) | 116 |
| abstract_inverted_index.(cGVHD) | 134 |
| abstract_inverted_index.Results | 90 |
| abstract_inverted_index.chronic | 131 |
| abstract_inverted_index.disease | 115, 133 |
| abstract_inverted_index.factors | 31 |
| abstract_inverted_index.infused | 100 |
| abstract_inverted_index.myeloid | 65 |
| abstract_inverted_index.options | 19 |
| abstract_inverted_index.overall | 141, 181 |
| abstract_inverted_index.present | 24 |
| abstract_inverted_index.relapse | 161, 254 |
| abstract_inverted_index.results | 225 |
| abstract_inverted_index.treated | 51 |
| abstract_inverted_index.Patients | 60 |
| abstract_inverted_index.achieved | 173 |
| abstract_inverted_index.complete | 151 |
| abstract_inverted_index.efficacy | 29 |
| abstract_inverted_index.infusion | 55 |
| abstract_inverted_index.interval | 202 |
| abstract_inverted_index.leukemia | 40, 235 |
| abstract_inverted_index.limited. | 21 |
| abstract_inverted_index.lymphoid | 68 |
| abstract_inverted_index.occurred | 135 |
| abstract_inverted_index.patients | 5, 37, 62, 75, 171, 232 |
| abstract_inverted_index.relapse, | 80, 199, 206 |
| abstract_inverted_index.relapse. | 89 |
| abstract_inverted_index.relapsed | 7, 46, 239 |
| abstract_inverted_index.response | 142 |
| abstract_inverted_index.survival | 35, 182, 220 |
| abstract_inverted_index.syndrome | 43 |
| abstract_inverted_index.Extensive | 130 |
| abstract_inverted_index.Objective | 0 |
| abstract_inverted_index.allo-HSCT | 48, 241 |
| abstract_inverted_index.diagnosed | 77, 84 |
| abstract_inverted_index.enrolled. | 73 |
| abstract_inverted_index.favorable | 258 |
| abstract_inverted_index.following | 47, 168, 221 |
| abstract_inverted_index.incidence | 111 |
| abstract_inverted_index.including | 146 |
| abstract_inverted_index.indicated | 226 |
| abstract_inverted_index.injection | 93 |
| abstract_inverted_index.molecular | 86, 251 |
| abstract_inverted_index.outcomes. | 259 |
| abstract_inverted_index.patients. | 139 |
| abstract_inverted_index.practice. | 59 |
| abstract_inverted_index.prognosis | 2 |
| abstract_inverted_index.remission | 152 |
| abstract_inverted_index.suggested | 243 |
| abstract_inverted_index.Conclusion | 223 |
| abstract_inverted_index.Cumulative | 160 |
| abstract_inverted_index.allogeneic | 9 |
| abstract_inverted_index.associated | 32, 215 |
| abstract_inverted_index.beneficial | 230 |
| abstract_inverted_index.cumulative | 110 |
| abstract_inverted_index.initiation | 125 |
| abstract_inverted_index.lymphocyte | 54 |
| abstract_inverted_index.real-world | 58 |
| abstract_inverted_index.relatively | 218 |
| abstract_inverted_index.(allo-HSCT) | 14 |
| abstract_inverted_index.Twenty-nine | 61 |
| abstract_inverted_index.combination | 247 |
| abstract_inverted_index.concomitant | 208 |
| abstract_inverted_index.cytogenetic | 88, 253 |
| abstract_inverted_index.therapeutic | 18 |
| abstract_inverted_index.chemotherapy | 209 |
| abstract_inverted_index.investigated | 27 |
| abstract_inverted_index.5-azacytidine | 211 |
| abstract_inverted_index.hematological | 79, 150 |
| abstract_inverted_index.hematopoietic | 10 |
| abstract_inverted_index.respectively. | 108, 179, 197 |
| abstract_inverted_index.significantly | 214 |
| abstract_inverted_index.CD3<sup>+</sup> | 101 |
| abstract_inverted_index.MDS<sup>4</sup> | 71 |
| abstract_inverted_index.myelodysplastic | 42 |
| abstract_inverted_index.transplantation | 13 |
| abstract_inverted_index.graft-versus-host | 114, 132 |
| abstract_inverted_index.leukemia<sup>4</sup> | 69 |
| abstract_inverted_index.Molecular/cytogenetic | 198 |
| abstract_inverted_index.molecular/cytogenetic | 158 |
| abstract_inverted_index.leukemia<sup>21</sup>, | 66 |
| abstract_inverted_index.5.0×10<sup>7</sup>/kg, | 107 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 12 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/1 |
| sustainable_development_goals[0].score | 0.5 |
| sustainable_development_goals[0].display_name | No poverty |
| citation_normalized_percentile.value | 0.78649298 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |